These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 27365369

  • 1. Treatment pathways in an inception lupus cohort over the first three years.
    Hanly JG, Sayani A, Doucette S, Iczkovitz S, Terres JAR.
    Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369
    [Abstract] [Full Text] [Related]

  • 2. Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.
    Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB.
    Arthritis Care Res (Hoboken); 2019 Jun; 71(6):822-828. PubMed ID: 30055090
    [Abstract] [Full Text] [Related]

  • 3. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
    Ugarte-Gil MF, Hanly J, Urowitz M, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen DL, Askanase A, Pons-Estel BA, Alarcón GS.
    Ann Rheum Dis; 2022 Nov; 81(11):1541-1548. PubMed ID: 35944946
    [Abstract] [Full Text] [Related]

  • 4. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
    Urowitz MB, Gladman DD, Ibañez D, Fortin PR, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Sanchez-Guerrero J, Wallace DJ, Ginzler E, Alarcón GS, Merrill JT, Bruce IN, Sturfelt G, Nived O, Steinsson K, Khamashta M, Petri M, Manzi S, Ramsey-Goldman R, Dooley MA, van Vollenhoven RF, Ramos M, Stoll T, Zoma A, Kalunian K, Aranow C.
    Arthritis Care Res (Hoboken); 2012 Jan; 64(1):132-7. PubMed ID: 21954226
    [Abstract] [Full Text] [Related]

  • 5. Disease evolution in late-onset and early-onset systemic lupus erythematosus.
    Aljohani R, Gladman DD, Su J, Urowitz MB.
    Lupus; 2017 Oct; 26(11):1190-1196. PubMed ID: 28420066
    [Abstract] [Full Text] [Related]

  • 6. Antimalarials in the treatment of systemic lupus erythematosus: a registry-based cohort study in Denmark.
    Nørgaard JC, Stengaard-Pedersen K, Nørgaard M, de Thurah A.
    Lupus; 2015 Mar; 24(3):299-306. PubMed ID: 25318969
    [Abstract] [Full Text] [Related]

  • 7. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
    Fanouriakis A, Adamichou C, Koutsoviti S, Panopoulos S, Staveri C, Klagou A, Tsalapaki C, Pantazi L, Konsta S, Mavragani CP, Dimopoulou D, Ntali S, Katsikas G, Boki KA, Vassilopoulos D, Konstantopoulou P, Liossis SN, Elezoglou A, Tektonidou M, Sidiropoulos P, Erden A, Sfikakis PP, Bertsias G, Boumpas DT.
    Semin Arthritis Rheum; 2018 Dec; 48(3):467-474. PubMed ID: 29555348
    [Abstract] [Full Text] [Related]

  • 8. The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.
    Ribi C, Trendelenburg M, Gayet-Ageron A, Cohen C, Dayer E, Eisenberger U, Hauser T, Hunziker T, Leimgruber A, Lindner G, Koenig K, Otto P, Spertini F, Stoll T, Von Kempis J, Chizzolini C, Swiss Systemic Lupus Erythematosus Cohort Study Group.
    Swiss Med Wkly; 2014 Dec; 144():w13990. PubMed ID: 25115978
    [Abstract] [Full Text] [Related]

  • 9. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
    Kwon HH, Bang SY, Won S, Park Y, Yi JH, Joo YB, Lee HS, Bae SC.
    Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
    [Abstract] [Full Text] [Related]

  • 10. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
    Vázquez-Otero I, Medina-Cintrón N, Arroyo-Ávila M, González-Sepúlveda L, Vilá LM.
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
    [Abstract] [Full Text] [Related]

  • 11. Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study.
    Touma Z, Sayani A, Pineau CA, Fortin I, Matsos M, Ecker GA, Chow A, Iczkovitz S.
    Rheumatol Int; 2017 Jun; 37(6):865-873. PubMed ID: 28280970
    [Abstract] [Full Text] [Related]

  • 12. Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.
    Ugarte-Gil MF, Wojdyla D, Pastor-Asurza CA, Gamboa-Cárdenas RV, Acevedo-Vásquez EM, Catoggio LJ, García MA, Bonfá E, Sato EI, Massardo L, Pascual-Ramos V, Barile LA, Reyes-Llerena G, Iglesias-Gamarra A, Molina-Restrepo JF, Chacón-Díaz R, Alarcón GS, Pons-Estel BA.
    Lupus; 2018 Apr; 27(4):536-544. PubMed ID: 28857715
    [Abstract] [Full Text] [Related]

  • 13. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB, Bae SC.
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [Abstract] [Full Text] [Related]

  • 14. Impact of telemedicine on disease activity assessment: A case-crossover study nested within a cohort of patients with systemic lupus erythematosus.
    Almaghlouth I, Almalag HM, Alzuhair H, Alsaigh R, Bedaiwi A, Hassen LM, Alzomia S, Alanazi B, Alabdulkareem AM, Alahmari S, Asfina KN, Khalil N, Omair MA, Bedaiwi M.
    Lupus; 2023 Dec; 32(14):1610-1618. PubMed ID: 37921574
    [Abstract] [Full Text] [Related]

  • 15. Prolonged clinical remission in patients with systemic lupus erythematosus.
    Steiman AJ, Urowitz MB, Ibañez D, Papneja A, Gladman DD.
    J Rheumatol; 2014 Sep; 41(9):1808-16. PubMed ID: 25086082
    [Abstract] [Full Text] [Related]

  • 16. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
    Zen M, Bassi N, Nalotto L, Canova M, Bettio S, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.
    Clin Exp Rheumatol; 2012 Sep; 30(6):856-63. PubMed ID: 22765883
    [Abstract] [Full Text] [Related]

  • 17. Serum uric acid is associated with damage in patients with systemic lupus erythematosus.
    Elera-Fitzcarrald C, Reátegui-Sokolova C, Gamboa-Cardenas RV, Medina M, Zevallos F, Pimentel-Quiroz VR, Cucho-Venegas JM, Alfaro-Lozano J, Rodriguez-Bellido Z, Pastor-Asurza CA, Perich-Campos RA, Alarcón GS, Ugarte-Gil MF.
    Lupus Sci Med; 2020 Sep; 7(1):e000366. PubMed ID: 32153795
    [Abstract] [Full Text] [Related]

  • 18. Prolonged remission in systemic lupus erythematosus.
    Urowitz MB, Feletar M, Bruce IN, Ibañez D, Gladman DD.
    J Rheumatol; 2005 Aug; 32(8):1467-72. PubMed ID: 16078321
    [Abstract] [Full Text] [Related]

  • 19. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED.
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [Abstract] [Full Text] [Related]

  • 20. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB, Schanberg LE, Thielman N, Phuti A, Kalla AA, Okpechi I, Nourse P, Gajjar P, Faller G, Ambaram P, Reuter H, Spittal G, Scott C.
    Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.